Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hyperpathia
100%
Systemic Administration
100%
Zymosan
100%
N [2 (3,4 Dichlorophenyl)ethyl] 2 Dimethylamino N Methylethylamine
100%
Immunoreactivity
66%
Oral
50%
Microglia
50%
Sigma 1 Opiate Receptor
50%
Cytokine
33%
calcium activated,phospholipid dependent protein kinase
33%
Receptor Antagonist
33%
Horn
33%
Mitogen Activated Protein Kinase P38
33%
Intrathecal Drug Administration
33%
Oral Drug Administration
16%
Interleukin 1
16%
Inflammatory Disorder
16%
Serositis
16%
Inflammatory Pain
16%
Thermal Hyperalgesia
16%
Minocycline
16%
Intraplantar Drug Administration
16%
Mechanical Hyperalgesia
16%
SB 203580
16%
Spinal Cord
16%
phosphorylation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperalgesia
100%
N [2 (3,4 Dichlorophenyl)ethyl] 2 Dimethylamino N Methylethylamine
100%
Systemic Administration
100%
Zymosan
100%
Rat
100%
Cytokine
33%
Receptor Antagonist
33%
calcium activated,phospholipid dependent protein kinase
33%
Mitogen Activated Protein Kinase P38
33%
Intrathecal
33%
Inflammation
16%
Inflammatory Disease
16%
Interleukin 1
16%
Oral Administration
16%
Inflammatory Pain
16%
Thermal Hyperalgesia
16%
SB 203580
16%
Neuroscience
Hyperalgesia
100%
Zymosan
100%
Microglia
50%
Sigma 1 Opiate Receptor
50%
P38 Mitogen-Activated Protein Kinases
33%
Cytokine
33%
Receptor Antagonist
33%
Intrathecal
33%
calcium activated,phospholipid dependent protein kinase
33%
Interleukin
33%
Spinal Cord
33%
Interleukin 1
16%
Protein Fos
16%
Mitogen Activated Protein Kinase 1
16%
Minocycline
16%
N Methyl Dextro Aspartic Acid Receptor 1
16%
Glia
16%
phosphorylation
16%